Get started in 90 seconds.

Six quick questions, designed by our clinical team. A GMC-registered doctor reviews your answers and, if treatment is clinically appropriate, our UK pharmacy partner dispenses and delivers your prescription.

Already know what you need? Skip to the contact step.

CQC

CQC-Registered clinical provider

Harley St

Real clinic, 134 Harley Street W1G

GMC

Named doctors, numbers published

<2hrs

Reply during clinic hours

What is your biological sex?

Some hair loss medicines (including finasteride and dutasteride) are not licensed for women and must not be taken by anyone who is or may become pregnant. This helps us route you to safe options at clinical review.

Which best represents your hair loss and goals?

Where are you noticing hair loss?

How much hair have you lost?

When did you start noticing changes to your hair?

Have you tried prescription hair loss treatment before?

Includes finasteride, minoxidil or anything a clinician has prescribed.

With treatment, what results are you hoping for?

Choose as many as apply.

Last step. Where do we send your plan?

A GMC-registered doctor reviews your answers and confirms whether treatment is clinically appropriate. If you're eligible, our UK pharmacy partner dispenses and delivers your prescription. We typically reply within two hours during clinic hours.

Company (leave blank)

First name

Last name

Email address

Phone number

By submitting you agree to be contacted by WMG Meds regarding your enquiry. Your data is handled per our Privacy Policy.

Enquiry received

A doctor will be in touch shortly.

A GMC-registered doctor will review your answers and confirm whether treatment is clinically appropriate. If you're eligible, your medication is dispensed and delivered to your door.

Suggested starting plan

See full plan details →

This is a suggested starting point only, not a prescription. Your GMC-registered doctor will review your full medical history and discuss the licensed indication, benefits and risks of any medicine before prescribing. If your plan includes finasteride or dutasteride, this will include the MHRA-listed risks (Drug Safety Updates 29 April 2024 and 11 May 2026): mood changes including depression and rarely suicidal thoughts, sexual side effects (reduced libido, erectile dysfunction, ejaculatory disorders) and the risk of persistent symptoms after stopping. Finasteride is not licensed for women and women who are or may become pregnant must not handle crushed or broken finasteride tablets, or handle leaking dutasteride capsules.